We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Announces “Stalking Horse” Agreement for the Sale of Zokinvy® (lonafarnib) Patient Access to Zokinvy® to Continue Uninterrupted PALO ALTO, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Eiger...
Eiger and Partner, AnGes, Receive Approval for Zokinvy® (lonafarnib) for Hutchinson- Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies in Japan PR Newswire PALO ALTO...
Eiger BioPharmaceuticals, Inc. Announces 1-for-30 Reverse Stock Split PR Newswire PALO ALTO, Calif., Jan. 4, 2024 PALO ALTO, Calif., Jan. 4, 2024 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | -3.475 | -66.8269230769 | 5.2 | 5.29 | 1.1 | 799809 | 1.75235168 | CS |
12 | -5.035 | -74.4822485207 | 6.76 | 8.2672 | 1.1 | 146911 | 2.04723216 | CS |
26 | -6.063 | -77.8505392912 | 7.788 | 14.33697 | 1.1 | 189078 | 6.08412273 | CS |
52 | -28.275 | -94.25 | 30 | 43.35 | 1.1 | 300199 | 16.53594372 | CS |
156 | -250.875 | -99.3171021378 | 252.6 | 300.639 | 1.1 | 432511 | 121.28807541 | CS |
260 | -336.075 | -99.4893428064 | 337.8 | 474.6 | 1.1 | 382222 | 183.39861566 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions